Research Paper Volume 13, Issue 5 pp 7499—7516
BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma
Figure 5. Correlation of BDKRB2 and key EMT biomarkers in pan-glioma (A, B) and glioblastoma (C, D).
Figure 5. Correlation of BDKRB2 and key EMT biomarkers in pan-glioma (A, B) and glioblastoma (C, D).